Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT
- PMID: 17317734
- DOI: 10.1378/chest.06-2356
Contrast echocardiography grading predicts pulmonary arteriovenous malformations on CT
Abstract
Background: Untreated pulmonary arteriovenous malformations (PAVMs) can present with life-threatening complications. Agitated saline solution transthoracic contrast echocardiography (TTCE) has been recommended as the screening test of choice for PAVMs in hereditary hemorrhagic telangiectasia (HHT). A TTCE grading system has been proposed but not validated. The aim of this study was to determine the positive predictive value (PPV) of TTCE grades for the presence of PAVMs on CT.
Methods: A blinded retrospective review was conducted. All patients screened at the Toronto HHT Center (June 2002 to September 2004) with positive TTCE results were included. TTCE results were scored for delay (number of cardiac cycles) before appearance of microcavitations in the left atrium and graded for intensity of opacification. Grade 1 indicates minimal left ventricular opacification, grade 2 indicates moderate opacification, grade 3 indicates extensive opacification without outlining the endocardium, and grade 4 indicates extensive opacification with endocardial definition. Thoracic CT was performed in all patients, and results were scored as positive, negative, or indeterminate for PAVMs.
Results: Of 155 patients screened for PAVMs, 104 had positive TTCE results. Complete data were available for 90 patients (87%). Mean age was 45 years; 62% were female. Seventeen percent of patients screened and 27% of patients with positive TTCE results had CT detectable PAVMs. There was a significant association between TTCE grade and presence of PAVMs on CT (p < 0.0001). The PPV of grades 1, 2, 3, and 4 were 0.02 (95% confidence interval, 0.00 to 0.06), 0.25 (95% confidence interval, 0.06 to 0.44), 0.56 (95% confidence interval, 0.23 to 0.88), and 1.0 (95% confidence interval, 1.0 to 1.0), respectively.
Conclusions: Increased shunt grade predicts increased probability of PAVMs and may be used to guide decisions in the screening algorithm for PAVMs.
Comment in
-
Patent foramen ovale or pulmonary arteriovenous malformation: an appeal for diagnostic accuracy.Chest. 2007 Jul;132(1):5-6. doi: 10.1378/chest.07-0577. Chest. 2007. PMID: 17625077 No abstract available.
Similar articles
-
Reliability of contrast echocardiography to rule out pulmonary arteriovenous malformations and avoid CT irradiation in pediatric patients with hereditary hemorrhagic telangiectasia.Echocardiography. 2015 Jan;32(1):42-8. doi: 10.1111/echo.12615. Epub 2014 May 9. Echocardiography. 2015. PMID: 24813063
-
Screening pulmonary arteriovenous malformations in a large cohort of Spanish patients with hemorrhagic hereditary telangiectasia.Int J Cardiol. 2016 Sep 1;218:240-245. doi: 10.1016/j.ijcard.2016.05.065. Epub 2016 May 14. Int J Cardiol. 2016. PMID: 27236122
-
Grading of pulmonary right-to-left shunt with transthoracic contrast echocardiography: does it predict the indication for embolotherapy?Chest. 2009 May;135(5):1288-1292. doi: 10.1378/chest.08-1266. Epub 2008 Dec 31. Chest. 2009. PMID: 19118272
-
Clinical implications of pulmonary shunting on saline contrast echocardiography.J Am Soc Echocardiogr. 2015 Mar;28(3):255-63. doi: 10.1016/j.echo.2014.12.008. Epub 2015 Jan 23. J Am Soc Echocardiogr. 2015. PMID: 25623000 Review.
-
Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).Respiration. 2007;74(4):361-78. doi: 10.1159/000103205. Respiration. 2007. PMID: 17641482 Review.
Cited by
-
Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects.Cardiovasc Diagn Ther. 2018 Jun;8(3):316-324. doi: 10.21037/cdt.2017.12.07. Cardiovasc Diagn Ther. 2018. PMID: 30057878 Free PMC article. Review.
-
Pulmonary arteriovenous malformations: endovascular therapy.Cardiovasc Diagn Ther. 2018 Jun;8(3):338-349. doi: 10.21037/cdt.2017.12.08. Cardiovasc Diagn Ther. 2018. PMID: 30057880 Free PMC article. Review.
-
A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark.Orphanet J Rare Dis. 2022 Jan 6;17(1):8. doi: 10.1186/s13023-021-02160-1. Orphanet J Rare Dis. 2022. PMID: 34991676 Free PMC article.
-
Significance of transesophageal contrast echocardiography with the agitated saline test for diagnosing pulmonary arteriovenous malformations.Front Cardiovasc Med. 2022 Sep 8;9:975901. doi: 10.3389/fcvm.2022.975901. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36158804 Free PMC article.
-
Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia.Neth Heart J. 2018 Apr;26(4):203-209. doi: 10.1007/s12471-018-1094-4. Neth Heart J. 2018. PMID: 29497946 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical